Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45–55 of the DMD gene, might improve patients’ symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45–55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44–56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction (RT-PCR), and identified a total of eight types of MES products around the hotspot. Surprisingly, the 5′ splice sites of recently reported post-transcriptional introns (r...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
Duchenne muscular dystrophy (DMD) is an X-linked recessive muscle wasting disorder characterised by ...
One promising approach for the gene therapy of Duchenne muscular dystrophy (DMD) is exon skipping. W...
International audienceA nonsense mutation c.4250T>A (p.Leu1417X) in the dystrophin gene of a patient...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
Duchenne muscular dystrophy (DMD) is an X-linked recessive muscle wasting disorder characterised by ...
One promising approach for the gene therapy of Duchenne muscular dystrophy (DMD) is exon skipping. W...
International audienceA nonsense mutation c.4250T>A (p.Leu1417X) in the dystrophin gene of a patient...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...
International audienceApproximately two-thirds of Duchenne muscular dystrophy (DMD) patients show in...